CVE-2024-52382

CVE-2024-52382 is a critical-severity vulnerability with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-862.

Key facts

Description

Missing Authorization vulnerability in medmatech Matix Popup Builder medma-matix allows Privilege Escalation.This issue affects Matix Popup Builder: from n/a through <= 1.0.0.

Frequently asked questions

What is CVE-2024-52382?
Missing Authorization vulnerability in medmatech Matix Popup Builder medma-matix allows Privilege Escalation.This issue affects Matix Popup Builder: from n/a through <= 1.0.0.
How severe is CVE-2024-52382?
CVE-2024-52382 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2024-52382 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (57th percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2024-52382?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
Does CVE-2024-52382 have an EU (EUVD) identifier?
Yes. CVE-2024-52382 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-45877.
When was CVE-2024-52382 published?
CVE-2024-52382 was published on 2024-11-14 and last updated on 2026-06-17.

References

Other CWE-862 (Missing Authorization) vulnerabilities

Browse all CWE-862 (Missing Authorization) vulnerabilities →